UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations

Familial cancer, 2023, Vol.22 (1), p.19-30

2023

Volltextzugriff (PDF)

The Effect of Inactivating Heterozygous Mutation in NBS1 Gene on DNA Damage and Repair Markers and Apoptosis Markers in Mice

Bulletin of experimental biology and medicine, 2023-06, Vol.175 (2), p.234-238

2023

Volltextzugriff (PDF)

Spectrum of APC and MUTYH germ‐line mutations in Russian patients with colorectal malignancies

Clinical genetics, 2018-05, Vol.93 (5), p.1015-1021

2018

Volltextzugriff (PDF)

The role of molecular diagnostics in the choice of therapy for biliary tract cancers

Sibirskiĭ onkologicheskiĭ zhurnal, 2024-03, Vol.23 (1), p.130-141

2024

Volltextzugriff (PDF)

Clinical characteristics of ovarian cancer relapse in BRCA1/2 germ-line mutation carriers and non-carriers

Annals of oncology, 2018-10, Vol.29, p.viii354-viii354

2018

Volltextzugriff (PDF)

Immune checkpoint inhibitors for the treatment of solid tumors in HIV-infected patients: is it worth the risk?

Sibirskiĭ onkologicheskiĭ zhurnal, 2023-02, Vol.22 (1), p.141-150

2023

Volltextzugriff (PDF)

Sequencing of KRAS and NRAS in 1501 colorectal carcinomas reveals significant share of mutations, which are not included in common diagnostic kits

Annals of oncology, 2018-10, Vol.29, p.viii195-viii195

2018

Volltextzugriff (PDF)

Final results of the concordance analysis of PD-L1 immunohistochemistry (IHC) assays and polymerase chain reaction (PCR) in non-small lung cancer (NSCLC) patients

Annals of oncology, 2018-10, Vol.29, p.viii507-viii507

2018

Volltextzugriff (PDF)

PALB2 germ-line mutations in Russian breast cancer patients: Identification of recurrent alleles and analysis of phenotypic characteristics of the tumors

Annals of oncology, 2018-10, Vol.29, p.viii76-viii76

2018

Volltextzugriff (PDF)

Distinct functional consequences of HER2 gene amplification in colorectal and lung adenocarcinomas

Annals of oncology, 2018-10, Vol.29, p.viii27-viii27

2018

Volltextzugriff (PDF)

Neoadjuvant eribulin plus carboplatin vs. paclitaxel plus carboplatin in patients with triple-negative breast cancer (TNBC)

Annals of oncology, 2018-10, Vol.29, p.viii88-viii89

2018

Volltextzugriff (PDF)

Lung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors

Annals of oncology, 2018-10, Vol.29, p.viii502-viii502

2018

Volltextzugriff (PDF)

HRD-negative high-grade carcinoma of the ovary in BRCA2 pathogenic variant carrier

Sibirskiĭ onkologicheskiĭ zhurnal, 2024-05, Vol.23 (2), p.139-146

2024

Volltextzugriff (PDF)

CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer

Clinical & translational oncology, 2021-04, Vol.23 (4), p.874-881

2021

Volltextzugriff (PDF)

Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations

Opukholi zhenskoĭ reproduktivnoĭ sistemy, 2016-09, Vol.12 (2), p.46-51

Imyanitov, E. N.

2016

Volltextzugriff (PDF)

BRCA1/2 mutation spectrum in Armenian patients with breast and ovarian cancers

Sibirskiĭ onkologicheskiĭ zhurnal, 2024-01, Vol.22 (6), p.83-91

2024

Volltextzugriff (PDF)

Predictive and prognostic features of early and locally advanced PIK3CA-mutated luminal HER2-negative breast cancer

Opukholi zhenskoĭ reproduktivnoĭ sistemy, 2024-01, Vol.19 (4), p.63-74

2024

Volltextzugriff (PDF)

Hereditary predisposition to kidney cancer: cancer syndromes, multisystemic disorders, and nephropathies

Sechenovskiĭ vestnik, 2023-08, Vol.14 (2), p.5-20

2023

Volltextzugriff (PDF)

Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review

American journal of epidemiology, 2006-12, Vol.164 (11), p.1027-1042

2006

Volltextzugriff (PDF)

Hereditary ovarian cancer

Sibirskiĭ onkologicheskiĭ zhurnal, 2022-11, Vol.21 (5), p.123-134

2022

Volltextzugriff (PDF)

Current approaches to systemic treatment of BRCA-associated triple-negative breast cancer

Uspehi molekulârnoj onkologii, 2023-10, Vol.10 (3), p.8-14

2023

Volltextzugriff (PDF)

Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome

Cancer treatment and research communications, 2022, Vol.31, p.100524-100524, Article 100524

2022

Volltextzugriff (PDF)

Molecular diagnosis in oncology

Molecular biology (New York), 2008-10, Vol.42 (5), p.687-698

Imyanitov, E. N

2008

Volltextzugriff (PDF)

Assessment of resection margins during breast-conserving surgery using multimodal optical coherence tomography

Opukholi zhenskoĭ reproduktivnoĭ sistemy, 2023-08, Vol.19 (2), p.34-46

2023

Volltextzugriff (PDF)

Reactivaion of immune-related colitis during targeted therapy in a patient with metastatic cutaneous melanoma

Sibirskiĭ onkologicheskiĭ zhurnal, 2022-11, Vol.21 (5), p.162-167

2022

Volltextzugriff (PDF)

1 – 25 von 280

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(262)
Mit Volltextzugriff
(189)

Publikationsform

Artikel
(277)
Berichte
(3)

Sprache

Englisch
(246)
Russisch
(71)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations

The Effect of Inactivating Heterozygous Mutation in NBS1 Gene on DNA Damage and Repair Markers and Apoptosis Markers in Mice

Spectrum of APC and MUTYH germ‐line mutations in Russian patients with colorectal malignancies

The role of molecular diagnostics in the choice of therapy for biliary tract cancers

Clinical characteristics of ovarian cancer relapse in BRCA1/2 germ-line mutation carriers and non-carriers

Immune checkpoint inhibitors for the treatment of solid tumors in HIV-infected patients: is it worth the risk?

Sequencing of KRAS and NRAS in 1501 colorectal carcinomas reveals significant share of mutations, which are not included in common diagnostic kits

Final results of the concordance analysis of PD-L1 immunohistochemistry (IHC) assays and polymerase chain reaction (PCR) in non-small lung cancer (NSCLC) patients

PALB2 germ-line mutations in Russian breast cancer patients: Identification of recurrent alleles and analysis of phenotypic characteristics of the tumors

Distinct functional consequences of HER2 gene amplification in colorectal and lung adenocarcinomas

Neoadjuvant eribulin plus carboplatin vs. paclitaxel plus carboplatin in patients with triple-negative breast cancer (TNBC)

Lung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors

HRD-negative high-grade carcinoma of the ovary in BRCA2 pathogenic variant carrier

CCND1 and FGFR1 gene amplifications are associated with reduced benefit from aromatase inhibitors in metastatic breast cancer

Evolution of systemic treatment for hormone-sensitive breast cancer: from sequential use of single agents to the upfront administration of drug combinations

BRCA1/2 mutation spectrum in Armenian patients with breast and ovarian cancers

Predictive and prognostic features of early and locally advanced PIK3CA-mutated luminal HER2-negative breast cancer

Hereditary predisposition to kidney cancer: cancer syndromes, multisystemic disorders, and nephropathies

Meta- and Pooled Analysis of GSTT1 and Lung Cancer: A HuGE-GSEC Review

Hereditary ovarian cancer

Current approaches to systemic treatment of BRCA-associated triple-negative breast cancer

Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome

Molecular diagnosis in oncology

Assessment of resection margins during breast-conserving surgery using multimodal optical coherence tomography

Reactivaion of immune-related colitis during targeted therapy in a patient with metastatic cutaneous melanoma

Suchergebnisse filtern